Pancreatic Cancer Research

ResearcherHumanitas UniversityNo recent work listed

Paola Allavena

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-6697-6028; OpenAlex author ID A5065211137. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 4 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 10

  1. Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreati… Last author DOI 10.3390/cancers14112653↗
  2. Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-021-00192-1↗
  3. Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells. Co-author DOI 10.1158/2326-6066.cir-19-0403↗
  4. Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype. Co-author DOI 10.1080/2162402x.2017.1393596↗
  5. Soluble stroma-related biomarkers of pancreatic cancer. Co-author DOI 10.15252/emmm.201708741↗
  6. Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma. Co-author DOI 10.1007/s00280-015-2932-3↗
  7. Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. Co-author DOI 10.1080/2162402x.2015.1085147↗
  8. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Co-author DOI 10.1136/gutjnl-2015-309193↗
  9. Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma… Co-author DOI 10.1242/dmm.026369↗
  10. Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system. Last author DOI 10.2174/13816128112092432↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Federica Marchesi · 5 shared papers, 2012–2022 · strength 0.34
  2. Giovanni Luigi Capretti · 4 shared papers, 2016–2022 · strength 0.30
  3. Alessandro Zerbi · 4 shared papers, 2016–2022 · strength 0.30
  4. Francesca Gavazzi · 4 shared papers, 2016–2022 · strength 0.30
  5. Paola Cappello · 4 shared papers, 2016–2020 · strength 0.29
  6. Francesco Novelli · 4 shared papers, 2016–2020 · strength 0.29
  7. Marialuisa Barbagallo · 2 shared papers, 2020–2022 · strength 0.20
  8. Giovanni Francesco Castino · 3 shared papers, 2016–2020 · strength 0.18
  9. Nina Cortese · 3 shared papers, 2016–2020 · strength 0.18
  10. Aldo Scarpa · 2 shared papers, 2018–2021 · strength 0.17
  11. Mohammad Azhar Kamal · 1 shared paper, 2022 · strength 0.12
  12. Luca Porcu · 2 shared papers, 2016–2018 · strength 0.12
  13. Michelle Rodriques Goulart · 1 shared paper, 2021 · strength 0.11
  14. Jennifer Watt · 1 shared paper, 2021 · strength 0.11
  15. Christine Hughes · 1 shared paper, 2021 · strength 0.11
  16. Somnath Mukherjee · 1 shared paper, 2021 · strength 0.11
  17. Chris N Hurt · 1 shared paper, 2021 · strength 0.11
  18. Rita Teresa Lawlor · 1 shared paper, 2021 · strength 0.11
  19. Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2021 · strength 0.11
  20. Hemant Mahendrakumar Kocher · 1 shared paper, 2021 · strength 0.11
  21. Roberto Salvia · 1 shared paper, 2021 · strength 0.11
  22. Giuseppe Di Caro · 2 shared papers, 2016 · strength 0.10
  23. Simone Borgoni · 1 shared paper, 2018 · strength 0.09
  24. Marco Erreni · 1 shared paper, 2020 · strength 0.08
  25. Greta Donisi · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.